Literature DB >> 15883266

Alzheimer disease and mortality: a 15-year epidemiological study.

Mary Ganguli1, Hiroko H Dodge, Changyu Shen, Rajesh S Pandav, Steven T DeKosky.   

Abstract

BACKGROUND: Alzheimer disease (AD) is considered a leading cause of death, but few studies have examined the contribution of AD to mortality based on follow-up of representative US cohorts.
OBJECTIVE: To examine mortality rates, duration of survival, causes of death, and the contribution of AD to the risk of mortality in an aging community-based cohort, controlling for other predictors.
DESIGN: Fifteen-year prospective epidemiological study. Mortality rates per 1000 person-years and the population-attributable risk of mortality were determined. Cox proportional hazards models were used to estimate relative risk of mortality due to AD, adjusting for relevant covariates. Death certificates were abstracted for listed causes of death.
SETTING: A largely blue-collar rural community in southwestern Pennsylvania. PARTICIPANTS: A community-based cohort of 1670 adults 65 years and older at study enrollment. MAIN OUTCOME MEASURE: Mortality.
RESULTS: In the overall cohort, AD was a significant predictor of mortality, with a hazard ratio of 1.4 after adjusting for covariates. The population-attributable risk of mortality from AD was 4.9% based on the same model. Examining the sexes separately, AD increased mortality risk only among women. Death certificates of AD subjects were more likely to list dementia/AD, other brain disorders, pneumonia, and dehydration, and less likely to include cancer.
CONCLUSIONS: Alzheimer disease was responsible for 4.9% of the deaths in this elderly cohort. Alzheimer disease increased the risk of mortality 40% in the cohort as a whole and separately in women but not in men. The mean (SD) duration of survival with AD was 5.9 (3.7) years, and longer with earlier age at onset.

Entities:  

Mesh:

Year:  2005        PMID: 15883266     DOI: 10.1001/archneur.62.5.779

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  68 in total

1.  Baseline differences and trajectories of change for deceased, placed, and community residing Alzheimer disease patients.

Authors:  Richard Schulz; Bozena Zdaniuk; Steven H Belle; Sara J Czaja; Henry Michael Arrighi; Arthur S Zbrozek
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Apr-Jun       Impact factor: 2.703

2.  Latent Classes of Neuropsychiatric Symptoms in NACC Controls and Conversion to Mild Cognitive Impairment or Dementia.

Authors:  Jeannie-Marie S Leoutsakos; Sarah N Forrester; Constantine G Lyketsos; Gwenn S Smith
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  Anti-Tumoral Activity of a Short Decapeptide Fragment of the Alzheimer's Abeta Peptide.

Authors:  Daniel Paris; Nikunj Patel; Nowell J Ganey; Vincent Laporte; Amita Quadros; Michael J Mullan
Journal:  Int J Pept Res Ther       Date:  2010       Impact factor: 1.931

4.  How many dementia cases in France and Europe? Alternative projections and scenarios 2010-2050.

Authors:  T Mura; J-F Dartigues; C Berr
Journal:  Eur J Neurol       Date:  2009-10-01       Impact factor: 6.089

5.  Genetic ablation of apolipoprotein A-IV accelerates Alzheimer's disease pathogenesis in a mouse model.

Authors:  Yujie Cui; Mingwei Huang; Yingbo He; Shuyan Zhang; Yongzhang Luo
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 6.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.

Authors:  Eric Karran; Marc Mercken; Bart De Strooper
Journal:  Nat Rev Drug Discov       Date:  2011-08-19       Impact factor: 84.694

7.  Terminal decline and practice effects in older adults without dementia: the MoVIES project.

Authors:  Hiroko H Dodge; Chia-Ning Wang; Chung-Chou H Chang; Mary Ganguli
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

Review 8.  A common biological mechanism in cancer and Alzheimer's disease?

Authors:  M I Behrens; C Lendon; C M Roe
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

9.  Survival in Alzheimer disease: a multiethnic, population-based study of incident cases.

Authors:  E P Helzner; N Scarmeas; S Cosentino; M X Tang; N Schupf; Y Stern
Journal:  Neurology       Date:  2008-11-04       Impact factor: 9.910

10.  Genetic Determinants of Survival in Patientswith Alzheimer’s Disease.

Authors:  Xingbin Wang; Oscar Lopez; Robert A Sweet; James T Becker; Steven T DeKosky; Mahmud M Barmada; Eleanor Feingold; F Yesim Demirci; M Ilyas Kamboh
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.